Drug & medication recalls Moderate risk

Hydromorphone 60 mg/ml + Fentanyl 20 recalled over sterility concerns

Recall date
June 2, 2015
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
The Compounding Pharmacy of America recalls Hydromorphone 60 mg/ml + Fentanyl 20,000 mcg/ml + Bupivacaine 40 mg/ml + Clonidine 1,000 mcg/ml + Baclofen 300 mcg/ml I…
Recall number
D-1677-2015
FDA classification
Class II
Brand / firm
The Compounding Pharmacy of America
Sold / distributed
Nationwide

Why it was recalled

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Hydromorphone 60 mg/ml + Fentanyl 20,000 mcg/ml + Bupivacaine 40 mg/ml + Clonidine 1,000 mcg/ml + Baclofen 300 mcg/ml Intrathecal Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN

Get recall alerts

Free email alert whenever The Compounding Pharmacy of America has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: The Compounding Pharmacy of America